We are live on ! Find out more
IART icon

Integra LifeSciences

249 hedge funds and large institutions have $4.87B invested in Integra LifeSciences in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 84 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 84

14% more call options, than puts

Call options by funds: $7.57M | Put options by funds: $6.64M

4.26% more ownership

Funds ownership: 82.58%86.85% (+4.3%)

4% more capital invested

Capital invested by funds: $4.67B → $4.87B (+$195M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

3% less funds holding

Funds holding: 257249 (-8)

10% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 40

Holders
249
Holders Change
-8
Holders Change %
-3.11%
% of All Funds
5.69%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
36
Increased
96
Reduced
84
Closed
40
Calls
$7.57M
Puts
$6.64M
Net Calls
+$933K
Net Calls Change
-$658K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$11.2M -$1.17M -18,859 -10%
Massachusetts Financial Services
52
Massachusetts Financial Services
Massachusetts
$10.4M +$665K +10,705 +7%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$10.1M -$167K -2,689 -2%
SEI Investments
54
SEI Investments
Pennsylvania
$9.72M -$2.03M -32,674 -18%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$9.53M +$143K +2,300 +2%
AIG
56
American International Group
New York
$9.49M +$105K +1,684 +1%
BG
57
Bellevue Group
Switzerland
$9.33M +$5.19M +83,459 +143%
KCM
58
Kennedy Capital Management
Missouri
$8.81M +$8.31M +133,795 New
SBH
59
Segall Bryant & Hamill
Illinois
$8.81M +$626K +10,079 +8%
Swiss National Bank
60
Swiss National Bank
Switzerland
$8.58M +$882K +14,200 +12%
CGT
61
Capital Guardian Trust
California
$8.53M +$2.72M +43,761 +51%
N
62
Natixis
France
$7.6M +$224K +3,598 +3%
TCIM
63
TIAA CREF Investment Management
New York
$7.36M -$3.26M -52,535 -32%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$7.28M -$160K -2,568 -2%
EVM
65
Eaton Vance Management
Massachusetts
$7.27M -$99.4K -1,599 -1%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$6.4M -$922K -14,830 -13%
Morgan Stanley
67
Morgan Stanley
New York
$6.19M -$3.92M -63,011 -40%
Retirement Systems of Alabama
68
Retirement Systems of Alabama
Alabama
$6.01M -$1.99K -32 -0%
MAM
69
Martingale Asset Management
Massachusetts
$5.83M -$827K -13,300 -13%
GLA
70
Great Lakes Advisors
Illinois
$5.73M -$699K -11,248 -11%
TA
71
Teachers Advisors
New York
$5.4M -$90.1K -1,450 -2%
Nordea Investment Management
72
Nordea Investment Management
Sweden
$5.09M +$4.8M +77,259 New
Legal & General Group
73
Legal & General Group
United Kingdom
$5.06M +$145K +2,333 +3%
New York State Teachers Retirement System (NYSTRS)
74
New York State Teachers Retirement System (NYSTRS)
New York
$5.01M
CIS
75
Capital International Sarl
California
$4.98M +$4.7M +75,600 New

IART Hedge Fund Activity: Q3 2018 in Review

249 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2018, worth a combined $4.87B — up 4.2% from $4.67B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of IART and 36 opened new positions — a net loss of 4 holders — while 84 trimmed existing stakes and 96 added.

The largest buyer was Wellington Management Group, adding an estimated $87.4M. The largest seller was Goldman Sachs, cutting an estimated $46.5M.

  • 249 institutional investors held Integra LifeSciences (IART) as of Q3 2018, down from 257 in Q2 2018.
  • Funds reported $4.87B of Integra LifeSciences stock for Q3 2018, up 4.2% quarter-over-quarter.
  • 36 funds opened new Integra LifeSciences positions in Q3 2018 and 40 closed out, a net change of -4 holders.
  • The largest Integra LifeSciences buyer in Q3 2018 was Wellington Management Group, an estimated $87.4M added.
  • The largest Integra LifeSciences seller in Q3 2018 was Goldman Sachs, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2018.